ACT-129968 (Setipiprant)
Important Notice: For research use only. We do not sell to patients.
Not your Region? View all Distributors
Important Notice: For research use only. We do not sell to patients.
Not your Region? View all Distributors
Discription | ACT-129968 is a potent and selective CRTH2 antagonist. | ||
---|---|---|---|
Targets |
|
Catalog Num | A15780 |
---|---|
Formula | C24H19FN2O3 |
Molecular Weight | 402.43 |
CAS Number | 866460-33-5 |
SMILES | FC(C=C1)=CC2=C1N(CC(O)=O)C3=C2CN(C(C4=CC=CC5=CC=CC=C54)=O)CC3 |
Synonyms | ACT 129968, ACT129968, KYTH-105, KYTH105, KYTH 105, Setipiprant |
Storage | Store lyophilized at -20ºC, keep desiccated. |
In vitro | DMSO | 69 mg/mL (171.46 mM) | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 24.85 mL | 124.25 mL | 248.49 mL |
0.5 mM | 4.97 mL | 24.85 mL | 49.7 mL |
1 mM | 2.48 mL | 12.42 mL | 24.85 mL |
5 mM | 0.5 mL | 2.48 mL | 4.97 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2